Daiki secures €1.5 million in seed funding to expand in Europe, enhance its AI platform, and help businesses navigate complex regulatory requirements.
DAIKI GmbH, an AI governance and compliance solutions provider based in Vienna, has secured €1.5 million in seed funding to support its European roll-out and further product development. The funding marks a significant milestone in Daiki’s mission to help businesses across Europe responsibly deploy AI.
Daiki offers a SaaS solution for AI governance and compliance with the EU AI Act and ISO standards, including ISO 13485 for medical device manufacturers. Built by a multidisciplinary team of experts, it offers an integrated document and quality management system (eQMS), streamlined processes for AI development, and an AI Copliot for successful AI implementation at scale.
Today, AI development involves complex legal, ethical, and technical issues that most organizations find difficult to manage. These challenges often slow innovation and make it harder for organizations to fully benefit from AI. Daiki tackles these challenges through its SaaS platform, which guides companies toward successful AI implementation. It saves time and money spent on costly consultants so organizations can focus on achieving real results with AI.
Also Read: Explained: Unsupervised Learning
After 18 months of bootstrapping, the company received €1.5 million in seed funding from Humanitas GmbH, an investment vehicle of Tarek Sherif. Tarek is the co-founder of Medidata Solutions and current Chairman of Dassault Systèmes’ Life Sciences Sector Board. With the newly secured seed funding, Daiki will accelerate its development efforts, including a new AI model registry feature. The funds will also scale the team and strengthen its European market presence.
Daiki currently caters to the MedTech, healthcare, and manufacturing sectors, focusing on the DACH region, the UK, the Netherlands, and Scandinavia. It also serves companies doing business in the EU, which must comply with the EU AI Act, across a broad range of industries. Daiki operates on a SaaS subscription model, offering discounted rates to research institutes, NGOs, and the public sector. With significant market potential, the company also counts the University Hospital Basel and Seco Tools among its customers.
Led by CEO Kevin Michael Gibney, an international sales and marketing executive with extensive experience in high-tech SaaS startups, Daiki additionally benefits from an experienced Advisory Board. Its members represent diverse expertise and feature leaders in AI governance, philosophy, UX design, and life sciences innovation.
Also Read: Explained: Semi-Supervised Learning
“To succeed in the European market, the effective and ethical development and deployment of AI must go hand in hand. Daiki demonstrates that, with the right technical tooling, it is possible to drive innovation while meeting complex regulatory requirements,” commented Daiki Advisory Board member Paula Cipierre.
